Skip to main content
. 2014 Sep 22;211(10):1925–1935. doi: 10.1084/jem.20140131

Table 2.

Self-renewal analysis of human AML-CB cotransplants with or without mobilization treatment

AML Patient 3 AML Patient 4 AML Patient 5
Engraftment outcomes Control Mobilized Control Mobilized Control Mobilized
AML only 0/4 0/3 0/3 0/5 1/1 2/5
AML + CB 4/4 3/3 2/3 1/5 0/1 2/5
CB only 0/4 0/3 1/3 4/5 0/1 1/5
Total mice 7 8 6

For each of three AML samples, it is indicated how many secondary transplant recipients were observed to have AML L-IC self-renewal, HSPC self-renewal, or both.